Drugs for the treatment of menopausal symptoms. - Wikidata - awgldk - TriplyDB

Drugs for the treatment of menopausal symptoms.

Drugs for the treatment of menopausal symptoms.

http://www.wikidata.org/entity/Q37735189

about

Female hormonal and reproductive factors and head and neck squamous cell carcinoma risk.Women's expectations and experiences of hormone treatment for sexual dysfunction.

P2860

Q35204278-5961EA17-EF4C-478B-A21C-0875F293BC79 Q51136922-FC7B1130-147F-4C64-BBAA-4318859D4FAC

P2860

Drugs for the treatment of menopausal symptoms.

http://www.wikidata.org/entity/Q37735189

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on June 2010

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Drugs for the treatment of menopausal symptoms.

@en

Drugs for the treatment of menopausal symptoms.

@nl

type

label

Drugs for the treatment of menopausal symptoms.

@en

Drugs for the treatment of menopausal symptoms.

@nl

prefLabel

Drugs for the treatment of menopausal symptoms.

@en

Drugs for the treatment of menopausal symptoms.

@nl

P1433

Q37735189-D20EB918-F29D-4FF9-B342-FCC81FE362BB

P1476

Q37735189-0145C66A-FA20-462B-8052-116AA01FCF1E

P2093

Q37735189-BE240C6D-31D8-4924-90AB-0B435090BED4

Q37735189-CB5FE387-610B-48C8-84B6-584C3442BF75

P2860

Q37735189-006C5030-40CB-46EB-83B9-1E1C7BC5CDC1

Q37735189-05A3A3EC-54DD-4A8B-B8B4-2B989D2B8B64

Q37735189-0705E61B-76D8-44D3-8AAC-9D4937508AED

Q37735189-08980AE7-A626-4943-83A1-DAE5F37BA666

Q37735189-0CF2478F-D354-4A72-B5DC-71A21F026156

Q37735189-1031481D-6FDD-4CD3-B785-EE653D109BE4

Q37735189-121C9B86-D4A4-4409-8F8B-AE9C159D0314

Q37735189-12FA3439-8CFF-438E-A85E-33285E7A55BA

Q37735189-16A81A2C-8728-48CB-9E8C-E67B66002BBA

Q37735189-1B4CB257-31CF-491A-B468-88BBD91F8578

P304

Q37735189-B59DA6CD-53C7-47F2-87B8-5A8F1295DF12

P31

Q37735189-F51B3F0C-1002-4022-B10C-6D1E98D66AE8

P356

Q37735189-E9126DF2-7BA4-4BA0-8AAF-700EAAA8A1A6

P407

Q37735189-556848EF-DE99-467B-83E8-5B9C2778917D

P433

Q37735189-7437683C-7185-4FA7-9908-6E94C43B66F7

P478

Q37735189-AFC53DAC-36EA-4747-A8B8-A1C7936F2D46

P50

Q37735189-7A8CB87D-664E-44A7-B188-339473FC3301

Q37735189-85E30BDB-6C4F-454C-9FD0-2FED47BD78D5

P577

Q37735189-B6FA9A73-BE17-4206-9750-96B907BBA807

P5875

Q37735189-3F3395A4-5665-4BB8-B743-EE5181380B8D

P698

Q37735189-18601C5E-A58B-401C-A812-C7F0A5951584

P356

14656561003742962

P1433

Expert Opinion on Pharmacotherapy

P1476

Drugs for the treatment of menopausal symptoms

@en

P2093

Fiona Jane

http://www.w3.org/2001/XMLSchema#string

Susan R Davis

http://www.w3.org/2001/XMLSchema#string

P2860

Estrogen and progestogen use in postmenopausal women: July 2008 position statement of The North American Menopause Society.

Dehydroepiandrosterone (DHEA), DHEA sulfate, and aging: contribution of the DHEAge Study to a sociobiomedical issue

Structure of the ligand-binding domain of oestrogen receptor beta in the presence of a partial agonist and a full antagonist

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Collaborative Group on Hormonal Factors in Breast Cancer

Differential association of oral and transdermal oestrogen-replacement therapy with venous thromboembolism risk

Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study

Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial

Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group

Differential effects on the androgen status of postmenopausal women treated with tibolone and continuous combined estradiol and norethindrone acetate replacement therapy.

P304

1329-1341

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/14656561003742962

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P50

P577

2010-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

43245969

http://www.w3.org/2001/XMLSchema#string

P698

20408747

http://www.w3.org/2001/XMLSchema#string